Cryo-EM structures of type IV pili complexed with nanobodies reveal immune escape mechanisms.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
18 Mar 2024
Historique:
received: 03 10 2023
accepted: 01 03 2024
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: epublish

Résumé

Type IV pili (T4P) are prevalent, polymeric surface structures in pathogenic bacteria, making them ideal targets for effective vaccines. However, bacteria have evolved efficient strategies to evade type IV pili-directed antibody responses. Neisseria meningitidis are prototypical type IV pili-expressing Gram-negative bacteria responsible for life threatening sepsis and meningitis. This species has evolved several genetic strategies to modify the surface of its type IV pili, changing pilin subunit amino acid sequence, nature of glycosylation and phosphoforms, but how these modifications affect antibody binding at the structural level is still unknown. Here, to explore this question, we determine cryo-electron microscopy (cryo-EM) structures of pili of different sequence types with sufficiently high resolution to visualize posttranslational modifications. We then generate nanobodies directed against type IV pili which alter pilus function in vitro and in vivo. Cyro-EM in combination with molecular dynamics simulation of the nanobody-pilus complexes reveals how the different types of pili surface modifications alter nanobody binding. Our findings shed light on the impressive complementarity between the different strategies used by bacteria to avoid antibody binding. Importantly, we also show that structural information can be used to make informed modifications in nanobodies as countermeasures to these immune evasion mechanisms.

Identifiants

pubmed: 38499587
doi: 10.1038/s41467-024-46677-y
pii: 10.1038/s41467-024-46677-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2414

Informations de copyright

© 2024. The Author(s).

Références

Denise, R., Abby, S. S. & Rocha, E. P. C. Diversification of the type IV filament superfamily into machines for adhesion, protein secretion, DNA uptake, and motility. PLoS Biol. 17, e3000390–34 (2019).
pubmed: 31323028 pmcid: 6668835 doi: 10.1371/journal.pbio.3000390
Berry, J. L. & Pelicic, V. Exceptionally widespread nanomachines composed of type IV pilins: The prokaryotic Swiss Army knives. FEMS Microbiol. Rev. 39, 1–21 (2015).
doi: 10.1093/femsre/fuu001
Ellison, C. K., Whitfield, G. B. & Brun, Y. V. Type IV Pili: Dynamic bacterial nanomachines. FEMS Microbiol. Rev. fuab053 https://doi.org/10.1093/femsre/fuab053 (2021).
Hobbs, M. M. et al. Experimental gonococcal infection in male volunteers: Cumulative experience with neisseria gonorrhoeae strains FA1090 and MS11mkC. Front. Microbiol. 2, 1–12 (2011).
doi: 10.3389/fmicb.2011.00123
Melican, K. M., Veloso, P., Martin, T., Bruneval, P. & Dumenil, G. Adhesion of neisseria meningitidis to dermal vessels leads to local vascular damage and purpura in a humanized mouse model. PLoS Pathog. 9, e1003139–11 (2013).
pubmed: 23359320 pmcid: 3554624 doi: 10.1371/journal.ppat.1003139
Miao, C., Cui, Y., Yan, Z. & Jiang, Y. Pilus of Streptococcus pneumoniae: Structure, function and vaccine potential. Front. Cell. Infect. Microbiol. 13, 1270848 (2023).
pubmed: 37799336 pmcid: 10548224 doi: 10.3389/fcimb.2023.1270848
Tramont, E. C. & Boslego, J. W. Pilus vaccines. Vaccine 3, 3–10 (1985).
Rotman, E. & Seifert, H. S. The genetics of neisseria species. Annu. Rev. Genet. 48, 405–431 (2014).
pubmed: 25251852 doi: 10.1146/annurev-genet-120213-092007
Cehovin, A. et al. Sequence conservation of pilus subunits in Neisseria meningitidis. Vaccine 28, 4817–4826 (2010).
pubmed: 20457291 doi: 10.1016/j.vaccine.2010.04.065
Wormann, M. E. et al. Sequence, distribution and chromosomal context of class I and class II pilin genes of Neisseria meningitidis identified in whole genome sequences. BMC Genomics 15, 1–15 (2014).
doi: 10.1186/1471-2164-15-253
Criss, A. K., Kline, K. A. & Seifert, H. S. The frequency and rate of pilin antigenic variation in Neisseria gonorrhoeae. Mol. Microbiol. 58, 510–519 (2005).
pubmed: 16194236 pmcid: 2657081 doi: 10.1111/j.1365-2958.2005.04838.x
Gault, J. et al. Neisseria meningitidis type IV Pili composed of sequence invariable pilins are masked by multisite glycosylation. PLOS Pathog. 11, e1005162 (2015).
pubmed: 26367394 pmcid: 4569582 doi: 10.1371/journal.ppat.1005162
Viburiene, R., Vik, A., Koomey, M. & Borud, B. Allelic variation in a simple sequence repeat element of neisserial pglb2 and its consequences for protein expression and protein glycosylation. J. Bacteriol. 195, 3476–3485 (2013).
pubmed: 23729645 pmcid: 3719539 doi: 10.1128/JB.00276-13
Chamot-Rooke, J. et al. Alternative Neisseria spp. type IV pilin glycosylation with a glyceramido acetamido trideoxyhexose residue. Proc. Natl. Acad. Sci. Usa. 104, 14783–14788 (2007).
pubmed: 17804791 pmcid: 1976187 doi: 10.1073/pnas.0705335104
Børud, B. et al. Genetic and molecular analyses reveal an evolutionary trajectory for glycan synthesis in a bacterial protein glycosylation system. Proc. Natl. Acad. Sci. 108, 9643–9648 (2011).
pubmed: 21606362 pmcid: 3111294 doi: 10.1073/pnas.1103321108
Naessan, C. L. et al. Genetic and functional analyses of PptA, a phospho-form transferase targeting type IV Pili in neisseria gonorrhoeae. J. Bacteriol. 190, 387–400 (2007).
pubmed: 17951381 pmcid: 2223744 doi: 10.1128/JB.00765-07
Chamot-Rooke, J. et al. Posttranslational modification of Pili upon Cell Contact Triggers N. meningitidis Dissemination. Science 331, 778–782 (2011).
pubmed: 21311024 doi: 10.1126/science.1200729
Kolappan, S. et al. Structure of the Neisseria meningitidis Type IV pilus. Nat. Commun. 7, 1–12 (2016).
doi: 10.1038/ncomms13015
Nassif, X. et al. Antigenic variation of pilin regulates adhesion of Neisseria meningitidis to human epithelial cells. Mol. Microbiol. 8, 719–725 (1993).
pubmed: 8332064 doi: 10.1111/j.1365-2958.1993.tb01615.x
Cahoon, L. A. & Seifert, H. S. An Alternative DNA Structure Is Necessary for Pilin Antigenic Variation in Neisseria gonorrhoeae. Science 325, 764–767 (2009).
pubmed: 19661435 pmcid: 2803317 doi: 10.1126/science.1175653
Kennouche, P. et al. Deep mutational scanning of the Neisseria meningitidismajor pilin reveals the importance of pilus tip-mediated adhesion. EMBO J. 38, 75–16 (2019).
doi: 10.15252/embj.2019102145
Pujol, C., Eugène, E., DesaintMartin, L. & Nassif, X. Interaction of Neisseria meningitidis with a polarized monolayer of epithelial cells. Infect. Immun. 65, 4836–4842 (1997).
pubmed: 9353073 pmcid: 175694 doi: 10.1128/iai.65.11.4836-4842.1997
Power, P. M. et al. Genetic characterization of pilin glycosylation in Neisseria meningitidis. Microbiology (Reading) 146, 967–979 (2000).
Jenne, C. N. & Kubes, P. Immune surveillance by the liver. Nat. Immunol. 14, 996–1006 (2013).
pubmed: 24048121 doi: 10.1038/ni.2691
Craig, L. et al. Type IV pilus structure by cryo-electron microscopy and crystallography: Implications for pilus assembly and functions. Mol. Cell 23, 651–662 (2006).
pubmed: 16949362 doi: 10.1016/j.molcel.2006.07.004
Law, C.-L. et al. Preclinical and nonclinical characterization of HPN217: A tri-specific T cell activating construct (TriTAC) targeting B cell maturation antigen (BCMA) for the treatment of multiple myeloma. Blood 132, 3225 (2018).
doi: 10.1182/blood-2018-99-113921
Stumpp, M. T., Binz, H. K. & Amstutz, P. DARPins: A new generation of protein therapeutics. Drug Discov. Today 13, 695–701 (2008).
pubmed: 18621567 doi: 10.1016/j.drudis.2008.04.013
Breine, A. et al. Bypassing the need for cell permeabilization: Nanobody CDR3 peptide improves binding on living bacteria. Bioconjug. Chem. 34, 1234–1243 (2023).
pubmed: 37418494 pmcid: 10360062 doi: 10.1021/acs.bioconjchem.3c00116
Kellogg, D. S., Cohen, I. R., Norins, L. C., Schroeter, A. L. & Reising, G. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J. Bacteriol. 96, 596–605 (1968).
pubmed: 4979098 pmcid: 252347 doi: 10.1128/jb.96.3.596-605.1968
Geoffroy, M.-C., Floquet, S., Métais, A., Nassif, X. & Pelicic, V. Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis. Genome Res 13, 391–398 (2003).
pubmed: 12618369 pmcid: 430250 doi: 10.1101/gr.664303
Klee, S. R. et al. Molecular and biological analysis of eight genetic islands that distinguish Neisseria meningitidis from the closely related pathogen Neisseria gonorrhoeae. 68, 2082–2095 (2000).
Marty, M. T. et al. Bayesian deconvolution of mass and ion mobility spectra: From binary interactions to polydisperse ensembles. Anal. Chem. 87, 4370–4376 (2015).
pubmed: 25799115 pmcid: 4594776 doi: 10.1021/acs.analchem.5b00140
Lafaye, P., Achour, I., England, P., Duyckaerts, C. & Rougeon, F. Single-domain antibodies recognize selectively small oligomeric forms of amyloid β, prevent Aβ-induced neurotoxicity and inhibit fibril formation. Mol. Immunol. 46, 695–704 (2009).
pubmed: 18930548 doi: 10.1016/j.molimm.2008.09.008
Gransagne, M. et al. Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein. J. Biol. Chem. 298, 101290 (2022).
pubmed: 34678315 doi: 10.1016/j.jbc.2021.101290
Moutel, S. et al. A multi-Fc-species system for recombinant antibody production. BMC Biotechnol. 9, 14 (2009).
pubmed: 19245715 pmcid: 2654441 doi: 10.1186/1472-6750-9-14
Li, T. et al. Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets. J. Controlled Release 243, 1–10 (2016).
doi: 10.1016/j.jconrel.2016.09.019
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466 pmcid: 5494038 doi: 10.1038/nmeth.4193
Zhang, K. Brief manual of gautomatch features. https://lab.rockefeller.edu/chen/assets/file/Gautomatch_Brief_Manual.pdf (2018).
Zivanov, J. et al. RELION-3: new tools for automated high-resolution cryo-EM structure determination. bioRxiv 421123 https://doi.org/10.1101/421123 (2018).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473 doi: 10.1038/nmeth.4169
Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721–745 (2003).
pubmed: 14568533 doi: 10.1016/j.jmb.2003.07.013
Pettersen, E. F. et al. UCSF Chimera - A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254 doi: 10.1002/jcc.20084
Casañal, A., Lohkamp, B. & Emsley, P. Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic Data. Protein Sci. Publ. Protein Soc. 29, 1069 (2020).
doi: 10.1002/pro.3791
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
pubmed: 34265844 pmcid: 8371605 doi: 10.1038/s41586-021-03819-2
Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis: UCSF ChimeraX Visualization System. Protein Sci. 27, 14–25 (2018).
pubmed: 28710774 doi: 10.1002/pro.3235
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. Struct. Biol. 74, 531–544 (2018).
doi: 10.1107/S2059798318006551
Lebedev, A. A. et al. JLigand: a graphical tool for the CCP4 template-restraint library. Acta Crystallogr. D. Biol. Crystallogr. 68, 431–440 (2012).
pubmed: 22505263 pmcid: 3322602 doi: 10.1107/S090744491200251X
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D. Biol. Crystallogr. 67, 235–242 (2011).
pubmed: 21460441 pmcid: 3069738 doi: 10.1107/S0907444910045749
Williams, C. J. et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
pubmed: 29067766 doi: 10.1002/pro.3330
Karami, Y. et al. Computational and biochemical analysis of type IV pilus dynamics and stability. Struct. Des. 1–20 https://doi.org/10.1016/j.str.2021.07.008 (2021).
Lemkul, J. A. & Bevan, D. R. Characterization of Interactions between PilA from Pseudomonas aeruginosa Strain K and a Model Membrane. J. Phys. Chem. B 115, 8004–8008 (2011).
pubmed: 21630674 doi: 10.1021/jp202217f
Rahman, M. M. et al. The membrane phospholipids of Neisseria meningitidis and Neisseria gonorrhoeae as characterized by fast atom bombardment mass spectrometry. Microbiol. Read. Engl. 146, 1901–1911 (2000).
doi: 10.1099/00221287-146-8-1901
Wu, E. L. et al. CHARMM‐GUI Membrane Builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997–2004 (2014).
Forest, K. T., Dunham, S. A., Koomey, M. & Tainer, J. A. Crystallographic structure reveals phosphorylated pilin from Neisseria: phosphoserine sites modify type IV pilus surface chemistry and fibre morphology. Mol. Microbiol. 31, 743–752 (1999).
pubmed: 10048019 doi: 10.1046/j.1365-2958.1999.01184.x
Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2, 19–25 (2015).
doi: 10.1016/j.softx.2015.06.001
Tribello, G. A., Bonomi, M., Branduardi, D., Camilloni, C. & Bussi, G. PLUMED 2: New feathers for an old bird. Comput. Phys. Commun. 185, 604–613 (2014).
doi: 10.1016/j.cpc.2013.09.018
Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71–73 (2017).
pubmed: 27819658 doi: 10.1038/nmeth.4067
Humphrey, W., Dalke, A. & Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
pubmed: 8744570 doi: 10.1016/0263-7855(96)00018-5

Auteurs

David Fernandez-Martinez (D)

Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.

Youxin Kong (Y)

Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.
Sanofi R&D, Integrated Drug Discovery, CRVA, 94403, Vitry-sur-Seine, France.

Sylvie Goussard (S)

Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.

Agustin Zavala (A)

Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.

Pauline Gastineau (P)

Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.

Martial Rey (M)

Institut Pasteur, Université Paris-Cité, CNRS, UAR 2024, Mass Spectrometry for Biology, 75015, Paris, France.

Gabriel Ayme (G)

Institut Pasteur, Université Paris-Cité, CNRS-UMR 3528, Antibody Engineering Platform, 75015, Paris, France.

Julia Chamot-Rooke (J)

Institut Pasteur, Université Paris-Cité, CNRS, UAR 2024, Mass Spectrometry for Biology, 75015, Paris, France.

Pierre Lafaye (P)

Institut Pasteur, Université Paris-Cité, CNRS-UMR 3528, Antibody Engineering Platform, 75015, Paris, France.

Matthijn Vos (M)

NanoImaging Core Facility, Center for Technological Resources and Research, Institut Pasteur, 75015, Paris, France.

Ariel Mechaly (A)

Institut Pasteur, Crystallography Platform-C2RT, CNRS-UMR 3528, Université Paris Cité, Paris, France.

Guillaume Duménil (G)

Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France. guillaume.dumenil@pasteur.fr.

Classifications MeSH